The estimated Net Worth of Michel Lagarde is at least $70.4 Milion dollars as of 14 May 2024. Mr. Lagarde owns over 20,000 units of Thermo Fisher Scientific stock worth over $23,584,354 and over the last 8 years he sold TMO stock worth over $40,845,381. In addition, he makes $6,005,860 as Executive Vice President at Thermo Fisher Scientific.
Michel has made over 7 trades of the Thermo Fisher Scientific stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 20,000 units of TMO stock worth $2,103,400 on 14 May 2024.
The largest trade he's ever made was selling 55,768 units of Thermo Fisher Scientific stock on 7 May 2021 worth over $26,181,403. On average, Michel trades about 2,664 units every 25 days since 2016. As of 14 May 2024 he still owns at least 38,134 units of Thermo Fisher Scientific stock.
You can see the complete history of Mr. Lagarde stock trades at the bottom of the page.
Michel Lagarde serves as Executive Vice President of the Company. Mr. Lagarde joined Thermo Fisher Scientific in August 2017 through the acquisition of Patheon and was appointed Senior Vice President and President, Pharma Services. From May 2016 to August 2017, Mr. Lagarde served as President and Chief Operating Officer at Patheon. From January 2008 to May 2016, Mr. Lagarde was Managing Director at JLL Partners, a private equity firm focused on healthcare.
As the Executive Vice President of Thermo Fisher Scientific, the total compensation of Michel Lagarde at Thermo Fisher Scientific is $6,005,860. There are 3 executives at Thermo Fisher Scientific getting paid more, with Marc Casper having the highest compensation of $19,023,100.
Michel Lagarde is 46, he's been the Executive Vice President of Thermo Fisher Scientific since 2019. There are 24 older and 2 younger executives at Thermo Fisher Scientific. The oldest executive at Thermo Fisher Scientific Inc. is Elaine Ullian, 71, who is the Independent Director.
Over the last 21 years, insiders at Thermo Fisher Scientific have traded over $356,502,416 worth of Thermo Fisher Scientific stock and bought 4,301 units worth $223,007 . The most active insiders traders include Thomas J Lynch, Dion J Weisler oraz Marc N Casper. On average, Thermo Fisher Scientific executives and independent directors trade stock every 23 days with the average trade being worth of $16,400,322. The most recent stock trade was executed by Marc N Casper on 3 September 2024, trading 20,000 units of TMO stock currently worth $4,213,600.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally.
Thermo Fisher Scientific executives and other stock owners filed with the SEC include: